(S1 (S (S (NP (NN ICBP90)) (VP (VBZ belongs) (PP (TO to) (NP (NP (DT a) (JJ new) (NN family)) (PP (IN of) (NP (NP (NNS proteins)) (PP (IN with) (NP (NP (DT an) (NN expression)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN deregulated) (PP (IN in) (NP (NN cancer) (NNS cells))))))))))))))) (. .)))
(S1 (S (S (NP (NP (NN ICBP90)) (PRN (-LRB- -LRB-) (NP (NP (JJ Inverted) (NN CCAAT) (NN box) (NN Binding) (NN Protein)) (PP (IN of) (NP (CD 90) (NN kDa)))) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB recently) (VBN identified)) (JJ nuclear) (NN protein)) (SBAR (WHNP (WDT that)) (S (VP (VBZ binds) (PP (TO to) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ inverted) (NN CCAAT) (NNS boxes)) (PP (IN of) (NP (DT the) (NN topoisomerase) (NN IIalpha) (-LRB- -LRB-) (NN TopoIIalpha) (-RRB- -RRB-) (NN gene) (NN promoter))))))))))))) (. .)))
(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN ICBP90)) (VP (VBZ shares) (NP (NP (JJ structural) (NN homology)) (PP (IN with) (NP (NP (JJ several) (JJ other) (NNS proteins)) (, ,) (PP (VBG including) (NP (NN Np95))) (, ,) (NP (DT the) (NP (ADJP (JJ human))) (CC and) (NP (NN mouse)) (NP (NN NIRF))))))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT the) (NN emergence)) (PP (IN of) (NP (NP (DT a) (JJ new) (NN family)) (PP (IN of) (NP (JJ nuclear) (NNS proteins))))))))) (. .)))
(S1 (S (PP (IN Towards) (S (VP (VBG elucidating) (NP (NP (DT the) (NNS functions)) (PP (IN of) (NP (DT this) (NN family))))))) (, ,) (NP (PRP we)) (VP (VBD analysed) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN ICBP90))) (PP (PP (IN in) (NP (JJ various) (NN cancer) (CC or) (NN noncancer) (NN cell) (NNS lines))) (CC and) (PP (IN in) (NP (JJ normal) (CC or) (NN breast) (NN carcinoma) (NNS tissues)))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NN cancer) (NN cell) (NNS lines)) (VP (VBP express) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NP (NN ICBP90)) (CC and) (NP (NN TopoIIalpha))))) (PP (IN than) (NP (JJ noncancer) (NN cell) (NNS lines)))))))) (. .)))
(S1 (S (S (PP (IN By) (S (VP (VBG using) (NP (JJ cell-cycle) (JJ phase-blocking) (NNS drugs))))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (JJ primary) (VBN cultured) (JJ human) (NN lung) (NNS fibroblasts))) (, ,) (NP (NN ICBP90) (NN expression)) (VP (VBZ peaks) (PP (PP (IN at) (NP (JJ late) (NN G1))) (CC and) (PP (IN during) (NP (NN G2/M) (NNS phases))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN cancer) (NN cell) (NNS lines)) (PP (JJ such) (IN as) (NP (NP (NN HeLa)) (, ,) (NP (NN Jurkat)) (CC and) (NP (NN A549))))) (VP (VBP show) (NP (JJ constant) (NN ICBP90) (NN expression)) (PP (IN throughout) (NP (DT the) (JJ entire) (NN cell) (NN cycle))))) (. .)))
(S1 (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (NN overexpression)) (PP (IN of) (NP (NN E2F-1)))))) (VP (VBZ is) (ADJP (RBR more) (JJ efficient)) (PP (IN on) (NP (NP (NN ICBP90)) (CC and) (NP (NN TopoIIalpha) (NN expression)))) (PP (IN in) (NP (JJ noncancer) (NNS cells))) (PRN (-LRB- -LRB-) (NP (CD IMR90)) (, ,) (NP (CD WI38)) (-RRB- -RRB-)) (PP (IN than) (PP (IN in) (NP (NN cancer) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NP (NNP U2OS)) (, ,) (NP (NN SaOs))) (-RRB- -RRB-))) (. .)))
(S1 (S (S (ADVP (RB Together)) (, ,) (NP (DT these) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (NN ICBP90) (NN expression)) (VP (VP (VBZ is) (VP (VBN altered) (PP (IN in) (NP (NN cancer) (NN cell) (NNS lines))))) (CC and) (VP (VBZ is) (VP (VBN upregulated) (PP (IN by) (NP (NN E2F-1) (NN overexpression))) (PP (IN with) (NP (NP (DT an) (NN efficiency)) (VP (VBG depending) (PP (IN on) (NP (NP (DT the) (NN cancer) (NN status)) (PP (IN of) (NP (DT the) (NN cell) (NN line))))))))))))))) (. .)))
